Abdel Jawad Mohammad, Munguti Cyrus M, Abu Kar Abdullah, Boppana Venkata, Fanari Zaher
Internal Medicine, Ascension Via Christi St. Francis, Wichita, USA.
Internal Medicine, University of Kansas, Wichita, USA.
Cureus. 2024 Jan 25;16(1):e52920. doi: 10.7759/cureus.52920. eCollection 2024 Jan.
Critical mitral valve stenosis due to a failed bioprosthetic valve is associated with significant morbidity and mortality, with the transcatheter Valve-in-Valve (ViV) approach becoming a popular treatment option. We present a case of cardiogenic shock secondary to a stenotic mitral bio-prosthetic valve. The Heart team was consulted; the patient was a high-risk surgical candidate for valve replacement. He required venoarterial extracorporeal membrane oxygenation as a bridge to definitive therapy. The patient underwent a successful urgent transcatheter mitral ViV procedure with a trans-septal approach. Follow-up echocardiography showed significant improvement in mitral valve dynamics. Recently emerging transcatheter approaches for mitral ViV implantation after balloon valvuloplasty into a failed mitral valve prosthesis are technically feasible in high-risk patient populations and should be considered over re-operative mitral valve surgery.
生物瓣膜功能衰竭导致的严重二尖瓣狭窄与显著的发病率和死亡率相关,经导管瓣中瓣(ViV)方法已成为一种流行的治疗选择。我们报告一例因二尖瓣生物瓣膜狭窄继发的心源性休克病例。心脏团队会诊后认为,该患者作为瓣膜置换手术的高危候选人,需要静脉-动脉体外膜肺氧合作为确定性治疗的桥梁。患者通过经房间隔途径成功接受了紧急经导管二尖瓣ViV手术。随访超声心动图显示二尖瓣动力学有显著改善。最近出现的在二尖瓣球囊瓣膜成形术后将ViV植入失败的二尖瓣假体的经导管方法在高危患者群体中技术上是可行的,应优先于再次手术二尖瓣手术考虑。